Ghost Tree Capital »

Biohaven shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 490k 34.71
2024-03-31 $16M 285k 54.69
2023-12-31 $12M 275k 42.80

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Biohaven

Vanguard Group
BlackRock
Stifel Financial
BlackRock
Henderson Group
Suvretta Capital Management
State Street Corporation
T. Rowe Price Associates
RP Management
Farallon Capital Management
Bellevue Group
Citadel Advisors
Geode Capital Management
Point72 Asset Management
Perceptive Advisors

View all funds holding Biohaven